US Bancorp DE lowered its stake in The Clorox Company (NYSE:CLX – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 126,665 shares of the company’s stock after selling 2,469 shares during the period. US Bancorp DE owned 0.10% of Clorox worth $20,572,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in CLX. Wealth Group Ltd. purchased a new position in shares of Clorox in the third quarter worth $231,000. Cigna Investments Inc. New purchased a new position in shares of Clorox in the third quarter worth $203,000. Latitude Advisors LLC purchased a new position in shares of Clorox in the third quarter worth $231,000. Van ECK Associates Corp raised its holdings in shares of Clorox by 2.2% in the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after buying an additional 31,510 shares during the last quarter. Finally, Intact Investment Management Inc. purchased a new position in shares of Clorox in the third quarter worth $75,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on the stock. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. DA Davidson cut their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and increased their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. JPMorgan Chase & Co. increased their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $159.62.
Clorox Stock Up 1.4 %
CLX stock opened at $156.52 on Monday. The firm has a market cap of $19.28 billion, a PE ratio of 42.76, a P/E/G ratio of 2.62 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The firm’s fifty day moving average is $156.88 and its 200 day moving average is $160.37. The Clorox Company has a one year low of $127.60 and a one year high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the business earned $2.16 EPS. On average, research analysts forecast that The Clorox Company will post 7.15 EPS for the current year.
Clorox Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.12%. Clorox’s dividend payout ratio (DPR) is 133.33%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- How is Compound Interest Calculated?
- Chaos and Cash: Finding Opportunity in Volatility
- Learn Technical Analysis Skills to Master the Stock Market
- Realty Income: An Anchor in Volatile Markets
- Why Are These Companies Considered Blue Chips?
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.